Halfdan Sørbye

13.1k total citations · 6 hit papers
160 papers, 8.1k citations indexed

About

Halfdan Sørbye is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Halfdan Sørbye has authored 160 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Oncology, 60 papers in Epidemiology and 32 papers in Neurology. Recurrent topics in Halfdan Sørbye's work include Colorectal Cancer Treatments and Studies (60 papers), Neuroendocrine Tumor Research Advances (58 papers) and Lung Cancer Research Studies (54 papers). Halfdan Sørbye is often cited by papers focused on Colorectal Cancer Treatments and Studies (60 papers), Neuroendocrine Tumor Research Advances (58 papers) and Lung Cancer Research Studies (54 papers). Halfdan Sørbye collaborates with scholars based in Norway, Sweden and Denmark. Halfdan Sørbye's co-authors include Bengt Glimelius, Bernard Nordlinger, Thomas Gruenberger, Wolf O. Bechstein, John Primrose, Peter M. Schlag, Graeme J. Poston, Euan Walpole, Rowan W. Parks and Werner Scheithauer and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Halfdan Sørbye

155 papers receiving 8.0k citations

Hit Papers

Perioperative chemotherapy with FOLFOX4 and surgery versu... 2008 2026 2014 2020 2008 2013 2012 2016 2016 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
    2008 1.4k citations Halfdan Sørbye, Bengt Glimelius et al. profile →
  2. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
    2013 853 citations Halfdan Sørbye, Bengt Glimelius et al. profile →
  3. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
    2012 714 citations Halfdan Sørbye, Staffan Welin et al. profile →
  4. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
    2016 403 citations Rocio García‐Carbonero, Halfdan Sørbye et al. Neuroendocrinology profile →
  5. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer
    2016 359 citations Halfdan Sørbye et al. profile →
  6. European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for digestive neuroendocrine carcinoma
    2023 75 citations Halfdan Sørbye, Marianne Pavel et al. Journal of Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halfdan Sørbye Norway 42 6.5k 3.4k 2.2k 2.1k 1.5k 160 8.1k
P. Rougier France 42 5.4k 0.8× 1.6k 0.5× 1.2k 0.6× 759 0.4× 2.4k 1.6× 115 8.0k
Laëtitia Dahan France 36 3.5k 0.5× 1.9k 0.6× 394 0.2× 1.2k 0.6× 1.5k 1.0× 144 5.3k
Rosine Guimbaud France 34 7.7k 1.2× 2.0k 0.6× 899 0.4× 445 0.2× 2.3k 1.5× 178 9.5k
Côme Lepage France 39 3.5k 0.5× 943 0.3× 988 0.4× 322 0.2× 1.8k 1.1× 214 5.3k
Nicola Fazio Italy 45 4.8k 0.7× 4.0k 1.2× 163 0.1× 2.7k 1.3× 944 0.6× 270 6.5k
Catherine Lombard‐Bohas France 39 5.3k 0.8× 5.1k 1.5× 218 0.1× 3.6k 1.7× 666 0.4× 168 6.7k
Matthew H. Kulke United States 62 9.3k 1.4× 8.3k 2.5× 227 0.1× 5.9k 2.8× 1.2k 0.8× 253 12.7k
Graeme J. Poston United Kingdom 42 6.4k 1.0× 779 0.2× 5.5k 2.5× 226 0.1× 3.5k 2.3× 142 9.3k
John F. Gibbs United States 39 2.1k 0.3× 829 0.2× 521 0.2× 324 0.2× 1.9k 1.3× 150 4.7k
Carlo Carnaghi Italy 29 2.0k 0.3× 747 0.2× 525 0.2× 433 0.2× 681 0.4× 93 3.3k

Countries citing papers authored by Halfdan Sørbye

Since Specialization
Citations

This map shows the geographic impact of Halfdan Sørbye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halfdan Sørbye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halfdan Sørbye more than expected).

Fields of papers citing papers by Halfdan Sørbye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halfdan Sørbye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halfdan Sørbye. The network helps show where Halfdan Sørbye may publish in the future.

Co-authorship network of co-authors of Halfdan Sørbye

This figure shows the co-authorship network connecting the top 25 collaborators of Halfdan Sørbye. A scholar is included among the top collaborators of Halfdan Sørbye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halfdan Sørbye. Halfdan Sørbye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McNamara, Mairéad G., Halfdan Sørbye, Nehara Begum, et al.. (2025). Controversies in NEN : An ENETS position statement on the treatment of patients with Grade 3 well‐differentiated neuroendocrine tumours of the gastro‐enteropancreatic tract. Journal of Neuroendocrinology. 37(12). e70080–e70080. 1 indexed citations
2.
Sørbye, Halfdan, Geir Olav Hjortland, Lene Weber Vestermark, et al.. (2025). Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study. British Journal of Cancer. 133(3). 316–324. 8 indexed citations
3.
Sørbye, Halfdan, Geir Olav Hjortland, Anna Sundlöv, et al.. (2024). NETest in advanced high‐grade gastroenteropancreatic neuroendocrine neoplasms. Journal of Neuroendocrinology. 36(11). e13428–e13428. 3 indexed citations
4.
Sørbye, Halfdan, Grace Kong, Simona Grozinsky‐Glasberg, & Jonathan Strosberg. (2024). PRRT in high‐grade digestive neuroendocrine neoplasms ( NET G3 and NEC ). Journal of Neuroendocrinology. 37(3). e13443–e13443. 5 indexed citations
5.
Langer, Seppo W., Anna Sundlöv, Lene Weber Vestermark, et al.. (2023). Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms. British Journal of Cancer. 129(12). 1930–1939. 11 indexed citations
6.
Knappskog, Stian, Tobias Grob, Ursula Amstutz, et al.. (2023). Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO Precision Oncology. 7(7). e2200336–e2200336. 12 indexed citations
7.
Lothe, Inger Marie Bowitz, Austin J. Borja, Siavash Mehdizadeh Seraj, et al.. (2022). Volumetric parameters from [ 18 F ] FDG PET / CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms. Journal of Neuroendocrinology. 34(7). e13170–e13170. 13 indexed citations
8.
9.
Pommergaard, Hans‐Christian, Halfdan Sørbye, Birgitte Federspiel, et al.. (2021). Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms. Journal of Neuroendocrinology. 33(5). e12967–e12967. 32 indexed citations
10.
Hicks, Rodney J., Clarisse Dromain, Wouter W. de Herder, et al.. (2021). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of Neuroendocrinology. 34(3). e13040–e13040. 13 indexed citations
11.
Rinke, Anja, Christoph J. Auernhammer, Lisa Bodei, et al.. (2021). Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?. Gut. 70(9). 1768–1781. 24 indexed citations
12.
Sørbye, Halfdan, et al.. (2021). Feminizing adrenal tumor identified by plasma steroid profiling. Endocrinology Diabetes and Metabolism Case Reports. 2021. 2 indexed citations
13.
Nunes, Luís, Lucy Mathot, Viktor Ljungström, et al.. (2020). Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis. Acta Oncologica. 59(4). 417–426. 18 indexed citations
14.
Grönberg, Malin, Seppo W. Langer, Morten Ladekarl, et al.. (2018). Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Medical Oncology. 35(4). 47–47. 10 indexed citations
15.
Sørbye, Halfdan, Éric Baudin, Ivan Borbath, et al.. (2018). Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3). Neuroendocrinology. 108(1). 54–62. 65 indexed citations
16.
García‐Carbonero, Rocio, Anja Rinke, Juan W. Valle, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy. Neuroendocrinology. 105(3). 281–294. 82 indexed citations
17.
Pavel, Marianne, Juan W. Valle, Barbro Eriksson, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 105(3). 266–280. 110 indexed citations
18.
Grönberg, Malin, Birgitte Federspiel, Jean‐Yves Scoazec, et al.. (2017). Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma. PLoS ONE. 12(11). e0187667–e0187667. 27 indexed citations
19.
García‐Carbonero, Rocio, Halfdan Sørbye, Éric Baudin, et al.. (2016). ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology. 103(2). 186–194. 403 indexed citations breakdown →
20.
Aaserud, Morten, Ivar Sønbø Kristiansen, Aileen Neilson, et al.. (2007). Helseøkonomisk evaluering av bevacizumab ved metastatisk kolorektalcancer. BIBSYS Brage (BIBSYS (Norway)). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Rougier Breakdown of academic impact, for papers by Laëtitia Dahan Breakdown of academic impact, for papers by Rosine Guimbaud Breakdown of academic impact, for papers by Côme Lepage Breakdown of academic impact, for papers by Nicola Fazio Breakdown of academic impact, for papers by Catherine Lombard‐Bohas Breakdown of academic impact, for papers by Matthew H. Kulke Breakdown of academic impact, for papers by Graeme J. Poston Breakdown of academic impact, for papers by John F. Gibbs Breakdown of academic impact, for papers by Carlo Carnaghi
Rankless by CCL
2026